CDH2 and non-small cell lung carcinoma: Yamauchi et al. stated that cadherin switch could also contribute, at least in part, to the survival mechanisms of gefitinib-resistant NSCLC cells, suggesting that under the influence of pemetrexed, N-cadherin expression can promote the acquisition of resistance to EGF-TKIs; this is consistent with our findings [31].